D-0007-2025 Class II Ongoing
Recall Details
- Product Type
- Drugs
- Report Date
- October 9, 2024
- Initiation Date
- September 23, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 99 doses
Product Description
Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61
Reason for Recall
CGMP deviations
Distribution Pattern
FL, MA, NJ, NY, PA, and VA
Code Information
Lot#: LPS240919B-16, 24-Sep-2024 Lot#: LPS240920B-16, 25-Sep-2024 Lot#: LPS240920C-16, 25-Sep-2024